These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 5850105)

  • 1. [Clinical use of a low molecular weight dextran].
    Larcan A; Calamai M; Genetet B
    Therapie; 1965; 20(5):1265-79. PubMed ID: 5850105
    [No Abstract]   [Full Text] [Related]  

  • 2. [Low molecular weight dextran and fibrinolysis in men. II. Fibrinolysis activation by administering low molecular weight dextran in lymphedema].
    Tesi M; Brunetti S
    Riv Crit Clin Med; 1967 Aug; 67(3):216-32. PubMed ID: 5633533
    [No Abstract]   [Full Text] [Related]  

  • 3. [The dextran of low molecular weight in the treatment of vascular retinal complications].
    Thomas C; Reny A; Raspiller A
    Bull Soc Ophtalmol Fr; 1967 Dec; 67(12):1163-5. PubMed ID: 5621637
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hemodynamic properties of low molecular dextran in experimental clinical conditions].
    Rudowski W; Kostrzewska E; Scharf R; Konopka L; Gregor A; Rechowicz K; Czartoryska B; Klawe Z; Ostrowski J
    Pol Tyg Lek; 1967 Oct; 22(45):1719-22. PubMed ID: 6063015
    [No Abstract]   [Full Text] [Related]  

  • 5. [Incidence of a low molecular weight (around 40,000) dextran solute on the mechanisms of hemostasis in the postoperative period].
    Lareng L; Ducos J; Boisson L; Virenque C; Lepert F; Quilici JC
    Presse Med (1893); 1967 Feb; 75(7):341-4. PubMed ID: 6016469
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dextran of low molecular weight in peripheral arterial insufficiency].
    Amoroso A; Guadagno L; Pozzi LL
    Omnia Med Ther; 1965; 43(1):151-67. PubMed ID: 5824979
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of diabetic retinopathy by perfusionsof low molecular weight dextran].
    Calmettes L; Deodati F; Bec P; Labro JB
    Bull Soc Ophtalmol Fr; 1967; 67(7):666-71. PubMed ID: 5598092
    [No Abstract]   [Full Text] [Related]  

  • 8. [Considerations on the use of dextran of low molecular weight in the treatment of peripheral arteriopathy].
    Serra GC; Verlato R
    Acta Anaesthesiol; 1965; 16():Suppl 5:87-95. PubMed ID: 5899665
    [No Abstract]   [Full Text] [Related]  

  • 9. [Contribution to the prevention of thrombo-embolic complications. Use of low molecular weight dextran solutions and intravascular platelet aggregation].
    Morin P; Choukroun J; Chabrier J
    Phlebologie; 1966; 19(1):43-7. PubMed ID: 5930155
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental fat embolism: evaluation of treatment with low molecular weight dextran.
    Lewis A; Pappas AM
    J Trauma; 1969 Jan; 9(1):49-55. PubMed ID: 5762585
    [No Abstract]   [Full Text] [Related]  

  • 11. The clinical status of low molecular weight dextran: a critical review.
    Couch NP
    Clin Pharmacol Ther; 1965; 6(5):656-65. PubMed ID: 5320593
    [No Abstract]   [Full Text] [Related]  

  • 12. [Observations and experiences in treatment of shock states with dextran of low molecular weight and corticosteroids in high doses].
    Serra GC; Simone M
    Acta Anaesthesiol; 1965; 16():Suppl 4:195+. PubMed ID: 5899705
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the treatment of the first phase of burn sickness with use of solutions of dextran of low molecular weight and mannitol].
    Serra GC
    Acta Anaesthesiol; 1965; 16():Suppl 5:73-86. PubMed ID: 5899664
    [No Abstract]   [Full Text] [Related]  

  • 14. [Dextran of low molecular weight (rheomacrodex) in the treatment of retinal circulatory disorders].
    Antoine F; Pierre I; Martinelle F
    Bull Soc Ophtalmol Fr; 1967 Dec; 67(12):1156-63. PubMed ID: 5621636
    [No Abstract]   [Full Text] [Related]  

  • 15. Some observations on the alteration of the adhesiveness of human blood platelets after infusion with low molecular weight dextran.
    Lal HB; Caroli RK; Sengupta D; Basumalik SN; Khan MA; Malik RN; Warrik HP
    J Assoc Physicians India; 1968 Aug; 16(8):523-7. PubMed ID: 5700157
    [No Abstract]   [Full Text] [Related]  

  • 16. [Management of acute myocardial infarct using low molecular dextran].
    Reutter FW; Mazzoni S; Wegmann T
    Schweiz Med Wochenschr; 1968 Aug; 98(33):1218-21. PubMed ID: 5682096
    [No Abstract]   [Full Text] [Related]  

  • 17. [Considerations on 3 cases of severe burn shock treated with low molecular weight dextran].
    Pallini C; Ristori M
    Osp Ital Chir; 1965 Nov; 13(5):491-8. PubMed ID: 5865416
    [No Abstract]   [Full Text] [Related]  

  • 18. The treatment of atherosclerotic peripheral arterial insufficiency with low molecular weight dextran intravenously.
    Lewis SR; Johnson JB
    J Natl Med Assoc; 1966 Jul; 58(4):261-4. PubMed ID: 5947681
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of a dextran derivative of low molecular weight for prevention of lesions of gastric mucosa due to deep hypothermia].
    Quarti-Trevano GM; Mirelli E; Puricelli C
    Arch Ital Chir; 1965; 91(1):90-5. PubMed ID: 5837413
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dextran with low molecular weight in the therapy of acute and chronic peripheral obstructive phlebopathies of the lower extremities].
    Maurizio A; Seghezzi R; Borri P; Taborelli R
    Minerva Chir; 1967 Feb; 22(4):173-8. PubMed ID: 6050196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.